Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T04:54:16.540Z Has data issue: false hasContentIssue false

The global spread of clinical trials

Published online by Cambridge University Press:  02 January 2018

David Skuse*
Affiliation:
Behavioural and Brain Sciences Unit, Institute of Child Health, London, UK, email [email protected]
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

There has been considerable publicity recently in the UK concerning the threatened contraction of the country's pharmaceutical industry. The UK currently has the third highest share of global pharmaceutical research and development expenditure (after the USA and Japan), but the costs of conducting research in the UK are rising.

Type
Thematic Papers
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2012

References

Academy of Medical Sciences (2011) A New Pathway for the Regulation and Governance of Health Research. Academy of Medical Sciences.Google Scholar
Reuters (2011) Special report: Big Pharma's global guinea pigs, 6 May. Available at http://www.reuters.com/article/2011/05/06/us-pharmaceuticals-trials-idUSTRE7450SV20110506 (accessed March 2012).Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.